×

Mylan CEO: 'Considerable less' profit from generic

4:41 PM ET Wed, 21 Sept 2016

Rep. Trey Gowdy (R-SC) questions Mylan CEO Heather Bresch about costs and compensation of the EpiPen and its generic equivalent at her hearing on Capitol Hill.